Jiangbo Wei
Impact in
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- Molecular Biology top 1%
- RNA modifications and cancer
- Cancer-related gene regulation
- RNA Research and Splicing
- RNA and protein synthesis mechanisms
- Epigenetics and DNA Methylation
Papers in
-
- Cancer-related molecular mechanisms research 14
-
- RNA modifications and cancer 34
- Cancer-related gene regulation 14
- RNA Research and Splicing 13
- RNA and protein synthesis mechanisms 4
Jiangbo Wei
43 papers receiving 4.9k citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Cancer Research 2.0k
- Molecular Biology 4.2k
- Organic Chemistry 510
- Pharmaceutical Science 99
- Oncology 382
Countries citing papers authored by Jiangbo Wei
This map shows the geographic impact of Jiangbo Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiangbo Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiangbo Wei more than expected).
Fields of papers citing papers by Jiangbo Wei
This network shows the impact of papers produced by Jiangbo Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiangbo Wei. The network helps show where Jiangbo Wei may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jiangbo Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 7 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 17 | |
| 4 | 2024 | 5 | |
| 5 | Exon architecture controls mRNA m 6 A suppression and gene expression Hit paper breakdown → | 2023 | 134 |
| 6 | 2023 | 55 | |
| 7 | 2023 | 11 | |
| 8 | 2023 | 30 | |
| 9 | m6A RNA modifications are measured at single-base resolution across the mammalian transcriptome Hit paper breakdown → | 2022 | 176 |
| 10 | 2022 | 1 | |
| 11 | 2021 | 74 | |
| 12 | 2021 | 27 | |
| 13 | 2021 | 37 | |
| 14 | 2021 | 50 | |
| 15 | 2020 | 30 | |
| 16 | m6A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade Hit paper breakdown → | 2019 | 565 |
| 17 | 2019 | 1 | |
| 18 | 2019 | 24 | |
| 19 | Differential m6A, m6Am, and m1A Demethylation Mediated by FTO in the Cell Nucleus and Cytoplasm Hit paper breakdown → | 2018 | 606 |
| 20 | ALKBH1-Mediated tRNA Demethylation Regulates Translation Hit paper breakdown → | 2016 | 439 |
About Jiangbo Wei
Jiangbo Wei is a scholar working on Cancer Research, Molecular Biology, Organic Chemistry, Energy Engineering and Power Technology and Pharmaceutical Science, having authored 45 papers that have together received 4.9k indexed citations. Recurring topics across this work include RNA modifications and cancer (34 papers), Cancer-related molecular mechanisms research (14 papers), Cancer-related gene regulation (14 papers), RNA Research and Splicing (13 papers), Catalytic C–H Functionalization Methods (10 papers), Catalytic Cross-Coupling Reactions (6 papers), Synthesis and Catalytic Reactions (5 papers) and RNA and protein synthesis mechanisms (4 papers). The work is most often cited by research in Cancer Research (2.0k citations), Molecular Biology (4.2k citations), Organic Chemistry (510 citations), Pharmaceutical Science (99 citations) and Oncology (382 citations). Jiangbo Wei has collaborated with scholars based in United States, China and Hong Kong. Frequent co-authors include Chuan He, Hailing Shi, Zhang‐Jie Shi, Zhike Lu, Xiaolong Cui, Arne Klungland, Fange Liu, Palak Shah, Yan‐Hong Cui and Yu‐Ying He. Their work appears in journals such as Nature Communications, Molecular Cell, Organic Letters, Chemical Communications and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.